Literature DB >> 29103046

Expanding the Clinical Spectrum of IgLON5-Syndrome.

Stephan Wenninger1.   

Abstract

Anti-IgLON5-syndrome is known to be an antibody-mediated disease that mainly affects central structures in tegmentum and hippocampus and leads to associated symptoms like sleep-related disturbances, parkinsonism, chorea and limb ataxia. This is the first case of a patient with anti-IgLON5-syndrome and generalized fasciculations and neuromyotonic discharges in electromyography, suggesting that a peripheral involvement may occur in anti-Ig-Lon5-syndromes.

Entities:  

Keywords:  Neuromyotonia; anti-IgLON5-syndrome; dysphagia; fasciculations; neuroimmunology

Mesh:

Substances:

Year:  2017        PMID: 29103046     DOI: 10.3233/JND-170259

Source DB:  PubMed          Journal:  J Neuromuscul Dis


  11 in total

Review 1.  The Sleep Disorder in Anti-lgLON5 Disease.

Authors:  Carles Gaig; Alex Iranzo; Joan Santamaria; Francesc Graus
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

2.  IgLON5 autoimmunity tested positive in patients with isolated chronic insomnia disease.

Authors:  Zahra Aghelan; Saeed Karima; Mohammad Rasoul Ghadami; Habibolah Khazaie; Fariborz Bahrehmand; Asad Vaisi-Raygani; Seyed Hosein Abtahi; Reza Khodarahmi
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

3.  Motor-neuron-disease-like phenotype associated with IgLON5 disease.

Authors:  Sri Raghav Sista; Brian Crum; Albert Aboseif; Michelle F Devine; Anastasia Zekeridou; M Bakri Hammami; Mohammed M Rezk; André Truffert; Patrice H Lalive; Amy Kunchok; Andrew McKeon; Divyanshu Dubey
Journal:  J Neurol       Date:  2022-07-20       Impact factor: 6.682

4.  Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.

Authors:  Carles Gaig; Yaroslau Compta; Anna Heidbreder; Maria J Marti; Maarten J Titulaer; Yvette Crijnen; Birgit Högl; Jan Lewerenz; María Elena Erro; Juan Carlos Garcia-Monco; Pasquale Nigro; Nicola Tambasco; Maja Patalong-Ogiewa; Marcus Erdler; Stefan Macher; Evelyn Berger-Sieczkowski; Romana Höftberger; Christian Geis; Markus Hutterer; Angela Milán-Tomás; Antonio Martin-Bastida; Lydia Lopez Manzanares; Sonia Quintas; Günter U Höglinger; Nora Möhn; Florian Schoeberl; Franziska S Thaler; Gian Maria Asioli; Federica Provini; Giuseppe Plazzi; Koldo Berganzo; Morten Blaabjerg; Norbert Brüggemann; Tarsis Farias; Chen Fei Ng; Caroline Giordana; Alejandro Herrero-San Martín; Lucio Huebra; Katya Kotschet; Herburg Liendl; Teresa Montojo; Carlos Morata; Jesus Perez Perez; Inmaculada Puertas; Thomas Seifert-Held; Caspar Seitz; Mateus Mistieri Simabukuro; Nieves Tellez; Javier Villacieros-Álvarez; Barbara Willekens; Lidia Sabater; Alex Iranzo; Joan Santamaria Cano; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2021-08-11       Impact factor: 11.800

Review 5.  Anti-IgLON 5 Disease.

Authors:  Anna Heidbreder; Konstanze Philipp
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

6.  Genetic variation in the body mass index of adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.

Authors:  Melissa A Richard; Austin L Brown; John W Belmont; Michael E Scheurer; Vidal M Arroyo; Kayla L Foster; Kathleen D Kern; Melissa M Hudson; Wendy M Leisenring; M Fatih Okcu; Yadav Sapkota; Yutaka Yasui; Lindsay M Morton; Stephen J Chanock; Leslie L Robison; Gregory T Armstrong; Smita Bhatia; Kevin C Oeffinger; Philip J Lupo; Kala Y Kamdar
Journal:  Cancer       Date:  2020-10-13       Impact factor: 6.860

Review 7.  Sleep Disturbances Associated with Neurological Autoimmunity.

Authors:  Michelle F Devine; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

8.  Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature.

Authors:  Mette Scheller Nissen; Morten Blaabjerg
Journal:  Front Neurol       Date:  2019-10-02       Impact factor: 4.003

9.  Anti-IgLON5 Disease: A New Bulbar-Onset Motor Neuron Mimic Syndrome.

Authors:  Jana Werner; Ilijas Jelcic; Esther Irene Schwarz; Elisabeth Probst-Müller; Jakob Nilsson; Bernhard Schwizer; Konrad Ernst Bloch; Andreas Lutterotti; Hans-Heinrich Jung; Bettina Schreiner
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-02-02

10.  Are Antibody Panels Under-Utilized in Movement Disorders Diagnosis? Yes.

Authors:  Bettina Balint
Journal:  Mov Disord Clin Pract       Date:  2021-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.